Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
AI Sentiment
Positive
7/10
as of 01-22-2026 3:58pm EST
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
| Founded: | 1937 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 11.7B | IPO Year: | N/A |
| Target Price: | $113.46 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.99 | EPS Growth: | -3.35 |
| 52 Week Low/High: | $81.36 - $128.28 | Next Earning Date: | 02-02-2026 |
| Revenue: | $2,813,367,000 | Revenue Growth: | 3.37% |
| Revenue Growth (this year): | 5.3% | Revenue Growth (next year): | 3.03% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
RVTY Breaking Stock News: Dive into RVTY Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
5/10
See how RVTY stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "RVTY Revvity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.